{"schema":"hottub-news/story/v1","story":"st_7xqtaos47duworry4msa","title":"Otsuka (OTCMKTS:OTSKY) vs. Inhibikase Therapeutics (NASDAQ:IKT) Financial Analysis","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/otsuka-otcmkts-otsky-vs-inhibikase-therapeutics-nasdaq-ikt-financial-7xqtaos47d","count":1,"items":[{"id":"n_7xqtaos47duworry4msa","seq":1635537,"kind":"article","title":"Otsuka (OTCMKTS:OTSKY) vs. Inhibikase Therapeutics (NASDAQ:IKT) Financial Analysis","url":"https://www.themarketsdaily.com/2026/10/04/otsuka-otcmktsotsky-vs-inhibikase-therapeutics-nasdaqikt-financial-analysis.html","published":"2026-10-04T07:50:42Z","seen":"2026-10-04T07:50:42Z","lang":"en","source":{"id":"themarketsdaily.com","name":"themarketsdaily.com","domain":"themarketsdaily.com"},"via":"gdelt-gkg-english","topics":["economy","education","health","business"],"authors":["Kim Johansen"],"entities":[{"id":"Q19001460","name":"Koichi Otsuka","type":"org"}],"story":"st_7xqtaos47duworry4msa","category":"economy-business","category_p":0.5400000214576721,"sentiment":"neutral","tone":0.23000000417232513,"political":0.10999999940395355}]}